Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety

Clinical trial NCT06816667 · COMPLETED

Trial details

NCT number: NCT06816667
Sponsor: Biomind Labs Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2024-10-21
Primary completion: 2025-02-14
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.